Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib mesylate--a new oral targeted therapy.

× No keyword cloud information.

168 in total

1. Pleomorph poorly differentiated endocrine carcinoma of the rectum.

Authors: Pellegrino Crafa; Massimo Milione; Cinzia Azzoni; Francesco Paolo Pilato; Silvia Pizzi; Cesare Bordi
Journal: Virchows Arch Date: 2003-05-07 Impact factor: 4.064

2. Prospect of anticancer therapy.

Authors: Hee-Sook Park
Journal: Cancer Res Treat Date: 2004-04-30 Impact factor: 4.679

3. Clinical implications of next-generation sequencing for cancer medicine.

Authors: A Shuen; W D Foulkes
Journal: Curr Oncol Date: 2010-10 Impact factor: 3.677

Review 4. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors: Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal: Bioorg Chem Date: 2020-11-19 Impact factor: 5.275

5. Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group.

Authors: S H Park; M H Ryu; B Y Ryoo; S A Im; H C Kwon; S S Lee; S R Park; B Y Kang; Y K Kang
Journal: Invest New Drugs Date: 2012-01-25 Impact factor: 3.850

6. A structure-guided approach to creating covalent FGFR inhibitors.

Authors: Wenjun Zhou; Wooyoung Hur; Ultan McDermott; Amit Dutt; Wa Xian; Scott B Ficarro; Jianming Zhang; Sreenath V Sharma; Joan Brugge; Matthew Meyerson; Jeffrey Settleman; Nathanael S Gray
Journal: Chem Biol Date: 2010-03-26

7. History of the Baylor Charles A. Sammons Cancer Center.

Authors: Marvin J Stone; Billie E Aronoff; W Phil Evans; Joseph W Fay; Z H Lieberman; Carolyn M Matthews; George J Race; R Pickett Scruggs; C Allen Stringer
Journal: Proc (Bayl Univ Med Cent) Date: 2003-01

Review 8. Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.

Authors: Bertrand Rochat
Journal: Clin Pharmacokinet Date: 2005 Impact factor: 6.447

9. A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).

Authors: Wolfram E Samlowski; James Moon; Ralph J Tuthill; Michael C Heinrich; Naomi S Balzer-Haas; Stuart A Merl; Ronald C DeConti; John A Thompson; Merle T Witter; Lawrence E Flaherty; Vernon K Sondak
Journal: Am J Clin Oncol Date: 2010-10 Impact factor: 2.339

10. A potential role for colony-stimulating factor 1 in the genesis of the early endometriotic lesion.

Authors: Jani R Jensen; Craig A Witz; Robert S Schenken; Rajeshwar R Tekmal
Journal: Fertil Steril Date: 2008-11-06 Impact factor: 7.329